Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Sohini Mondal

Earnings Preview: What to Expect From DexCom's Report

Based in San Diego, California, DexCom, Inc. (DXCM), with a market cap of $44.8 billion, is a leader in the medical device sector, specializing in continuous glucose monitoring systems for diabetes management. The company is set to unveil its fiscal Q2 earnings results after the market closes on Thursday, Jul. 25.

Ahead of this event, analysts expect DXCM to report a profit of $0.39 per share, up 14.7% from $0.34 per share in the year-ago quarter. The company holds a solid track record of surpassing Wall Street's bottom-line estimates in each of the past four quarters. In the most recent quarter, the company’s adjusted EPS of $0.32 climbed a notable 88.2% annually, surpassing the consensus estimate by a solid 18.5% margin due to strong demand for glucose monitoring.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.